Optical genome mapping is a new technology used for whole genome mapping to enable precision diagnostics of genetic diseases. Optical mapping utilizes optical microscopy to capture images of elongated, individual DNA molecules to determine their physical arrangement (map), including structural variants and epigenetic features. It helps in characterizing the whole genome architecture of an organism and provides important insights about genetic variation and disease association. The technology has applications in cancer research, personalized medicine, and human genome mapping projects. Advantages of optical genome mapping over conventional genome sequencing methods include its ability to detect complex structural variations, epigenetic features as well as complete circular genomes of bacteria and plasmids. Growing prevalence of genetic disorders and cancer along with increasing focus on precision medicine is driving the demand for genomic studies, fueling the growth of the optical genome mapping market.
The Global Optical Genome Mapping Market is estimated to be valued at US$ 109.9 MN in 2024 and is expected to exhibit a CAGR of 21 % over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Global Optical Genome Mapping Market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.
Growing demand for personalized medicine, cancer research, and prenatal diagnosis of genetic diseases is a major factor driving the optical genome mapping market. Advancements in technology allowing for high-throughput analysis, target identification and treatment strategies is fueling the adoption of optical genome mapping.
Technological developments such as integration of artificial intelligence and machine learning algorithms for big data analysis of optical maps, development of portable devices for point-of-care applications, and integration of optical mapping with other OMICs technologies will further expand the application scope of optical genome mapping.
Fastest Growing Region in Optical Genome Mapping Market
Asia Pacific region is poised to witness the fastest growth in the optical genome mapping market during the forecast period from 2024 to 2031. This can be attributed to factors like - increasing government funding for genomics research, rapidly developing healthcare infrastructure, rising healthcare expenditure, growing efforts to sequence human genomes, expanding biopharmaceutical industry and presence of emerging economies like India and China driving higher investments in life science research. Moreover, growing incidence of genetic diseases and cancer and rising awareness levels regarding precision medicine offer huge potential for optical genome mapping services in Asia Pacific.
Get more insights on Global Optical Genome Mapping Market